1. Home
  2. BFC vs COLL Comparison

BFC vs COLL Comparison

Compare BFC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

N/A

Current Price

$141.42

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$43.22

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFC
COLL
Founded
1894
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
BFC
COLL
Price
$141.42
$43.22
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$150.00
$51.17
AVG Volume (30 Days)
74.1K
278.5K
Earning Date
04-23-2026
05-28-2026
Dividend Yield
1.43%
N/A
EPS Growth
N/A
N/A
EPS
5.36
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$58.67
$26.20
Revenue Next Year
$2.01
$3.54
P/E Ratio
$26.48
$35.74
Revenue Growth
N/A
23.62
52 Week Low
$93.00
$23.23
52 Week High
$153.00
$50.79

Technical Indicators

Market Signals
Indicator
BFC
COLL
Relative Strength Index (RSI) 53.45 36.14
Support Level $118.71 $34.30
Resistance Level $153.00 $48.74
Average True Range (ATR) 4.03 1.32
MACD -1.23 -0.20
Stochastic Oscillator 33.54 28.18

Price Performance

Historical Comparison
BFC
COLL

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: